About: Uniformity of captopril benefit in the SAVE Study: subgroup analysis. Survival and Ventricular Enlargement Study

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Uniformity of captopril benefit in the SAVE Study: subgroup analysis. Survival and Ventricular Enlargement Study Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 May 1994

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) наукова стаття, опублікована в травні 1994 (uk) im Mai 1994 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu en mayu de 1994 (ast) scientific article published on 01 May 1994 (en)
publication date	wds:Q72164104-72F617FC-DA75-4197-ADF0-1885A47CD3A5
publication date	1994-05-01 00:00:00Z (xsd:dateTime)
author name string	wds:Q72164104-04458B97-BBE5-4537-9F6C-76BEC02731FF wds:Q72164104-080939D3-2957-4294-8B34-5E9C2CEAC09E wds:Q72164104-12C6B629-E39A-44A9-8982-2BA37FF89A76 wds:Q72164104-1F41749F-5DEC-4327-B6C3-33DE39C62853 wds:Q72164104-53F5630D-B9BC-47C8-996E-407E86F7CF24 wds:Q72164104-647C32E8-947C-43F4-983C-E0F6E3F61E52 wds:Q72164104-67C49897-D4E9-4F4D-899A-531F4ED5DA9F wds:Q72164104-A3E28074-6BD6-42F8-8947-63B4B82F1C81 wds:Q72164104-EAB7DD7B-350D-4C83-98C0-BADAECD7DCAA wds:Q72164104-F048822A-A79C-4976-AC9F-4E05812E8B54
author name string	B R Davis L A Moyé H Dinh D Hayes O S Randall M A Pfeffer C C Wun J M Arnold D J Farnham E Geltman
rdfs:label	Uniformity of captopril benefit in the SAVE Study: subgroup analysis. Survival and Ventricular Enlargement Study (en) Uniformity of captopril benefit in the SAVE Study: subgroup analysis. Survival and Ventricular Enlargement Study (nl)
skos:prefLabel	Uniformity of captopril benefit in the SAVE Study: subgroup analysis. Survival and Ventricular Enlargement Study (en) Uniformity of captopril benefit in the SAVE Study: subgroup analysis. Survival and Ventricular Enlargement Study (nl)
name	Uniformity of captopril benefit in the SAVE Study: subgroup analysis. Survival and Ventricular Enlargement Study (en) Uniformity of captopril benefit in the SAVE Study: subgroup analysis. Survival and Ventricular Enlargement Study (nl)
title	wds:Q72164104-9FF2CE5B-DCC0-44F9-9566-ACB7FF1E6CCC
title	Uniformity of captopril benefit in the SAVE Study: subgroup analysis. Survival and Ventricular Enlargement Study (en)
page(s)	wds:Q72164104-6EA3E6CF-6F8E-41B4-B406-A95320D9D629
page(s)	2-8; discussion 26-30
instance of	wds:Q72164104-F64A4DBA-0E22-4465-9BEF-7387668F748E
instance of	scholarly article
PubMed ID	wds:Q72164104-2571AA65-EC42-4604-BBE6-DAEF55ACBF9D
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8076658
PubMed ID	8076658
published in	wds:Q72164104-073AC017-9593-48D2-869D-328AE6E896A8
published in	European Heart Journal
volume	wds:Q72164104-0247B5CF-FA54-4266-813C-D8295FBEDAAF
volume	15 Suppl B
DOI	wds:Q72164104-C0BA1C02-8EB0-42B9-A047-FAD779B2033E
DOI	http://dx.doi.org/10.1093/EURHEARTJ/15.SUPPL_B.2
DOI	10.1093/EURHEARTJ/15.SUPPL_B.2
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q72164104
is cites work of	Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment. Management of coronary artery disease: therapeutic options in patients with diabetes Heart disease in diabetes mellitus Efficacy of angiotensin-converting enzyme inhibitors and beta-blockers in the management of left ventricular systolic dysfunction according to race, gender, and diabetic status: a meta-analysis of major clinical trials Management of cardiac health in trastuzumab-treated patients with breast cancer: updated United Kingdom National Cancer Research Institute recommendations for monitoring Managing myocardial infarction in the diabetic patient Epidemiology of myocardial infarction in France: Therapeutic and prognostic implications of heart failure during the acute phase Predictors of mortality in acute heart failure: interaction between diabetes and impaired left ventricular ejection fraction Diabetes increases mortality after myocardial infarction by oxidizing CaMKII Cardiac event rates after acute myocardial infarction in patients treated with verapamil and trandolapril versus trandolapril alone. Danish Verapamil Infarction Trial (DAVIT) Study Group. Verapamil and angiotensin-converting enzyme inhibitors in patients with coronary artery disease and reduced left ventricular ejection fraction. Effect of the angiotensin-converting enzyme inhibitor trandolapril on mortality and morbidity in diabetic patients with left ventricular dysfunction after acute myocardial infarction Risk factor management in diabetic and non-diabetic patients with coronary heart disease. Findings from the EUROASPIRE I AND II surveys Antihypertensive therapy for preventing cardiovascular complications in people with diabetes mellitus Comparison of effectiveness of angiotensin-converting enzyme inhibitors after acute myocardial infarction in diabetic versusnondiabetic patients Captopril. A review of its pharmacology and therapeutic efficacy after myocardial infarction and in ischaemic heart disease Management of type 2 diabetes mellitus and cardiovascular risk: lessons from intervention trials [Heart pathology of extracardiac origin. XI. Cardiac repercussions of diabetes mellitus] What cardiologists need to know about diabetes. ACE inhibitors and calcium antagonists in the treatment of congestive heart failure Blood pressure targets for hypertension in patients with type 2 diabetes. Impact of pharmacological treatment on mortality after myocardial infarction in diabetic patients Diabetes mellitus and cardiovascular disease
is cites work of	wds:Q34125415-8ADBC8B4-73D3-4DC1-8715-DF13F6E1E316 wds:Q33910165-A5977A8A-7D5B-4CB1-AA3C-56A9DC12629C wds:Q41107253-E69E39A9-1D0E-407A-9C1A-BCDB85068025 wds:Q37123487-B5A71DCC-D301-489D-BD4A-597E8971E829 wds:Q40945910-7B805926-5D5A-4C61-A84E-F10169F493D6 wds:Q50560376-11AADDF1-5CF6-40A1-AB78-0BD8AD4B4226 wds:Q54120661-AA9052B5-7093-4032-9314-A0BCB5232C2B wds:Q33996007-AE70368D-B71F-4225-80F5-CA51E575A71C wds:Q41431060-8E40997D-F048-494D-9B81-8B9D1756D29A wds:Q40931110-C7853278-FE21-4C35-BC9B-EAEA934BBC4B wds:Q44965057-733EEB05-698C-44A5-8A27-46927D8E5162 wds:Q61918814-9A126D9C-6D19-498F-B60D-51BB72335433 wds:Q88027525-F7721A0E-36F0-4B22-AAAA-366353C35818 wds:Q79218916-2DB0B529-AC01-46A3-8E07-9092B130B95B wds:Q30540314-648F9674-6FEF-4039-9CA0-C2E52A0175C3 wds:Q34196279-0B4B2FA4-9D03-4444-9E7D-02021BD9377A wds:Q37882500-1213847C-F42B-457D-AF48-59BB92E37AFC wds:Q41556867-BD5AB23E-30E0-46F1-96C4-E0D0DB366985 wds:Q57658645-AC578BFB-BAF6-4909-8FE5-E4E0BB382FA4 wds:Q64977297-21021702-CACC-48AA-8138-4E180B0AB8A2 wds:Q34112942-0E554CA5-27B6-4326-B5ED-7A278F0526F1 wds:Q53986171-30D5A0B1-841F-4AB9-9B5E-EF8FC2A5DF0F wds:Q77616770-24C97518-7166-493E-9D33-0B48631A2ED1

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 171 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software